Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03748992 · ClinicalTrials.gov registry record · Phase 2
A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT03748992 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 10 participants.
The verdict
NCT03748992, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy and safety of open-label exposure of gNO in patients with NTM lung disease. Subjects will receive the study drug by inhaling through a nasal mask. Subjects will be treated for 3 weeks (5 days per week) and followed monthly for 3 months.
Interventions
- DRUG gNO
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-01-28 |
| Est. Completion | 2020-03-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03748992
The ClinicalTrials.gov registry entry for NCT03748992 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which gNO is the first listed.
NCT03748992 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03748992 about?
NCT03748992 is a clinical study titled "A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection". The purpose of this study is to evaluate the efficacy and safety of open-label exposure of gNO in patients with NTM lung disease. Subjects will receive the study drug by inhaling through a nasal mask. Subjects will be treated for 3 weeks (5 days per week) and followed monthly for 3 months.
What is the current status of trial NCT03748992?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2019-01-28. Estimated completion is 2020-03-26.
What interventions are being tested in trial NCT03748992?
The interventions under investigation include: gNO (DRUG).
Who is sponsoring clinical trial NCT03748992?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.